United States Pharmacopoeia (USP) Solutions and Reagents
United States Pharmacopoeia (USP) solutions and reagents are crucial for ensuring the safety, quality, and efficacy of pharmaceuticals in the U.S. market. These products comply with the standards set by the USP and are widely used in drug development and quality control. CymitQuimica offers a comprehensive range of USP-compliant solutions and reagents to support pharmaceutical research and manufacturing.
Found 7624 products of "United States Pharmacopoeia (USP) Solutions and Reagents"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Ranitidine Related Compound C (N-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]sulfinyl]ethyl]-N-methyl-2-nitro-1,1-ethenediamine)
CAS:Compounds containing an unfused furan ring, whether or not hydrogenated, in the structure, nesoiFormula:C13H22N4O4SColor and Shape:Off-White SolidMolecular weight:330.13618Abacavir Stereoisomers Mixture
Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureColor and Shape:White Off-White PowderTetrahydrozoline Related Compound E (N-(2-Aminoethyl)-1,2,3,4-tetrahydronaphthalene-1-carboxamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormula:C13H18N2OColor and Shape:White SolidMolecular weight:218.3 g/molSkim Milk Powder with Melamine - Level E
Products consisting of natural milk constituents, except whey, whether or not containing added sugar or other sweeteners, nesoiColor and Shape:White Cream Solidcis-Lurasidone Hydrochloride (rel-(3aR,4S,7R,7aS)-2-(((1R,2S)-2-((4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)methyl)cyclohexyl)methyl)hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione, hydrochloride)
CAS:Compounds containing a benzothiazole ring-system (whether or not hydrogenated), not further fusedFormula:C28H36N4O2S·HClColor and Shape:White Off-White SolidMolecular weight:528.232587-Keto abiraterone Acetate
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C26H31NO3Color and Shape:White Off-White PowderMolecular weight:405.23039Memantine Related Compound E (N-3,5-Dimethyladamantan-1-yl formamide)
CAS:Cyclic amides and their derivatives, nesoiFormula:C13H21NOColor and Shape:White PowderMolecular weight:207.16231Dalteparin Sodium
CAS:Heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or includedFormula:C9H20N3NaO3Color and Shape:PowderMolecular weight:2000 - 9000 daltonsFentanyl Related Compound A ((2-bromoethyl)benzene)
CAS:Halogenated derivatives of aromatic hydrocarbons not elFormula:C8H9BrColor and Shape:LiquidMolecular weight:185.07 g/molOseltamivir Phosphate
CAS:Cyclic amides and their derivatives, nesoiFormula:C16H28N2O4·H3PO4Color and Shape:White Fine Crystalline PowderMolecular weight:312.20491Disodium Inosinate
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C10H11N4Na2O8P·xH2OColor and Shape:White Translucent PowderMolecular weight:410.19Rivastigmine Tartrate R-Isomer ((R)-3-[1-(Dimethylamino)ethyl]phenyl ethyl(methyl)carbamate, hydrogen tartrate)
Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormula:C14H22N2O2·C4H6O6Color and Shape:White PowderMolecular weight:250.16813Zanamivir Related Compounds Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiColor and Shape:SolidIsoguaifenesin
CAS:Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFormula:C10H14O4Color and Shape:Off-White PowderMolecular weight:198.08921Metyrapone
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C14H14N2OColor and Shape:White PowderMolecular weight:226.27 g/mol6-Ethylpyrimidine-2,4-diamine (6-Ethylpyrimidine-2,4-diamine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C6H10N4Color and Shape:Off-White Fine PowderMolecular weight:138.09055Ethoxytrimethoprim Analog (5-(4-Ethoxy-3,5-dimethoxybenzyl)pyrimidin-2,4-diamine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C15H20N4O3Color and Shape:Off-White SolidMolecular weight:304.15354Metaraminol Related Compound A ((E)-1-[3-(benzyloxy)phenyl]-2-(hydroxyimino)propan-1-one)
CAS:Aromatic imines and their derivatives, salts thereofFormula:C16H16NO3Color and Shape:Off-White SolidMolecular weight:270.11302Clopidogrel Diester Enantiomer Sulfate ((S)-1-(2-chlorophenyl)-2-methoxy-2-oxoethyl (R)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate, sulfate)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C24H21Cl2NO4S·H2SO4Color and Shape:White Off-White SolidMolecular weight:489.05683Desogestrel Related Compound C (13-Ethyl-11-methylene-18,19-dinor-17α-pregn-4-en-20-yn-17-ol-3-one)
CAS:Estrogens and progestinsFormula:C22H28O2Color and Shape:White Crystalline PowderMolecular weight:324.20893Bosentan Related Compound A (4-(tert-butyl)-N-[6-chloro-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl] benzenesulfonamide)
CAS:Sulfonamides, nesoiFormula:C25H24ClN5O4SColor and Shape:White PowderMolecular weight:525.12375Betamethasone Valerate System Suitability Mixture (A mixture containing betamethasone valerate and betamethasone valerate related compound H)
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiColor and Shape:White PowderFluorometholone
CAS:Halogenated derivatives of adrenal cortical hormonesFormula:C22H29FO4Color and Shape:White Light Yellow Crystalline PowderMolecular weight:376.20499Ivabradine N-Oxide (3-(7,8-dimethoxy-2-oxo-1,2,4,5-tetrahydro-3H-benzo[d]azepin-3-yl)-N-(((S)-3,4-dimethoxybicyclo[4.2.0]octa-1(6),2,4-trien-7-yl)methyl)-N-methylpropan-1-amine oxide)
CAS:Lactams, nesoiFormula:C27H36N2O6Color and Shape:Off-White SolidMolecular weight:484.25734Gonadorelin Acetate Related Compound A (5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosylglycyl-L-leucyl-L-arginyl-L-prolylglycine)
CAS:Polypeptide, protein and glycoprotein hormones, their derivatives and structural analogues, nesoiFormula:C55H74N16O14Color and Shape:White PowderMolecular weight:1182.55704Verapamil Related Compound B (4-[(3,4-Dimethoxyphenethyl)(methyl)amino]-2-(3,4-dimethoxyphenyl)-2-isopropylbutanenitrile hydrochloride)
CAS:Nitrile function compounds, nesoiFormula:C26H36N2O4·HClColor and Shape:White Crystalline PowderMolecular weight:477.05Ketotifen Fumarate
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H19NOS·C4H4O4Color and Shape:White Brownish Yellow PowderMolecular weight:309.11874β-Methylcholine Chloride (2-Hydroxy-N,N,N-trimethylpropan-1-aminium chloride)
CAS:Quaternary ammonium salts and hydroxides, whether or not chemically defined, otherFormula:C6H16ClNOColor and Shape:White Light Yellow Crystalline PowderMolecular weight:153.65Cariprazine BOC-Amine (tert-Butyl [(1r,4r)-4-{2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl}cyclohexyl]carbamate)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C23H35Cl2N3O2Color and Shape:White PowderMolecular weight:455.21063Lumefantrine Related Compound A ((RS, Z)-2-(Dibutylamino)-2-(2,7-dichloro-9-(4-chlorobenzylidene)-9H-fluoren-4-yl)ethanol hydrochloride)
Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFormula:C30H32Cl3NO·HClColor and Shape:Yellow PowderMolecular weight:527.15495Azacitidine Formyl Amidine Analog (N-(Formyl amidino)-N'-β-D-ribofuranosylurea)
CAS:Compounds containing an unfused furan ring, whether or not hydrogenated, in the structure, nesoiFormula:C8H14N4O6Color and Shape:Off-White SolidMolecular weight:262.09133Linezolid R-Isomer (N-{[(R)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl]methyl}acetamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C16H20FN3O4Color and Shape:White Off-White Solid PowderMolecular weight:337.14378Clonazepam Related Compound A (3-Amino-4-(2-chlorophenyl)-6-nitrocarbostyril)
CAS:Lactams not elsewhere specified or includedFormula:C15H10ClN3O3Color and Shape:Yellow-Orange PowderMolecular weight:315.72Residual Solvent Class 1 - 1,1,1-Trichloroethane (Ozone Depleting Substance)
<p>Methylchloroform (1,1,1-trichloroethane)</p>Color and Shape:LiquidEletriptan Hydrobromide (3-[[(R)-1-Methyl-2-pyrrolidinyl]methyl]-5-[2-(phenylsulfonyl)ethyl]indole monohydrobromide monohydrate)
CAS:Analgesics, antipyretics and non-hormonal anti-inflammatory agentsFormula:C22H26N2O2S·HBr·H2OColor and Shape:Off-White Light Brown PowderMolecular weight:481.45Etodolac Related Compound H (2-(7-Ethyl-1H-indol-3-yl)ethan-1-ol)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C12H15NOColor and Shape:Light Yellow Red Crystalline PowderMolecular weight:189.11536Verbascoside
CAS:Other glycosides, natural or reproduced by synthesis, and their salts, ethers, esters and other derivativesFormula:C29H36O15Color and Shape:White Off-White Pale Yellow PowderMolecular weight:624.59 g/molSulfanilamide Melting Point Standard (Approximately 165 degrees)
CAS:Sulfonamides used as drugsFormula:C6H8N2O2SColor and Shape:White Off-White Crystalline PowderMolecular weight:172.21 g/molCortisone Acetate
CAS:Adrenal cortical hormones and their derivatives nesoiFormula:C23H30O6Color and Shape:White Off-White PowderMolecular weight:402.20424Fluocinonide
CAS:Halogenated derivatives of adrenal cortical hormonesFormula:C26H32F2O7Color and Shape:White Cream PowderMolecular weight:494.21161Rifabutin
CAS:Antibiotics nesoiFormula:C46H62N4O11Color and Shape:Dark Violet PowderMolecular weight:846.44151Zolmitriptan Related Compound F (2,2'-[4-(Dimethylamino)butane-1,1-diyl]bis{5-[(S)-(2-oxooxazolidin-4-yl)methyl]-3-(2-dimethylaminoethyl)indole})
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C38H53N7O4Color and Shape:Orange PowderMolecular weight:671.4159Penicillin G Sodium
CAS:Penicillin g and its saltsFormula:C16H18N2O4S·NaColor and Shape:PowderMolecular weight:357.0885Abiraterone System Suitability Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiColor and Shape:White PowderIohexol Related Compound C (N,N'-Bis(2,3-dihydroxypropyl)-5-nitro-1,3- benzenedicarboxamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormula:C14H19N3O8Color and Shape:White PowderMolecular weight:357.11721Choline Fenofibrate (2-Hydroxy-N,N,N-trimethylethanaminium 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate)
CAS:Choline and its saltsFormula:C17H14ClO4·C5H14NOColor and Shape:White PowderMolecular weight:421.91 g/molRanitidine Related Compound A (5-{[(2-Aminoethyl)thio]methyl}-N,N-dimethyl-2-furanmethanamine hemifumarate)
CAS:Compounds containing an unfused furan ring, whether or not hydrogenated, in the structure, nesoiFormula:C10H18N2OSC4H4O4Color and Shape:Off-White Crystalline PowderMolecular weight:272.36Methylprednisolone Hemisuccinate Related Compound D (11β,17-Dihydroxy-6α-methyl-3,20-dioxopregna-4-en-21-yl hydrogen succinate)
CAS:Adrenal cortical hormones and their derivatives nesoiFormula:C26H36O8Color and Shape:White Off-White SolidMolecular weight:476.24102Cefotaxime Related Compound E ((Z)-2-(2-aminothiazol-4-yl)-N-{(5aR,6R)-1,7-dioxo-1,3,4,5a,6,7-hexahydroazeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl}-2-(methoxyimino)acetamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C14H13N5O5S2Color and Shape:Off-White Light Yellow PowderMolecular weight:395.03581Anethole
CAS:Aromatic ethers and their halogenated, sulfonated, nitrFormula:C10H12OColor and Shape:Colorless LiquidMolecular weight:148.2Benazepril Related Compound D (3-(1-Ethoxycarbonyl-3-cyclohexyl-(1S)-propyl)amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine-1-acetic acid monohydrochloride)
CAS:Lactams, nesoiFormula:C24H34N2O5·HClColor and Shape:White Fine PowderMolecular weight:430.24677Betaine Hydrochloride
CAS:Quaternary ammonium salts and hydroxides, whether or not chemically defined, otherFormula:C5H11NO2·HClColor and Shape:White Crystalline PowderMolecular weight:153.61Fexofenadine N-oxide (1-(4-(4-(2-carboxypropan-2-yl)phenyl)-4-hydroxybutyl)-4-(hydroxydiphenylmethyl)piperidine 1-oxide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C32H39NO5Color and Shape:White Off-White SolidMolecular weight:517.67Fluconazole Related Compound B (2-(4-Fluorophenyl)-1,3-di(1H-1,2,4-triazol-1-yl)-propan-2-ol)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C13H13FN6OColor and Shape:White PowderMolecular weight:288.28Glycyl-L-Glutamine
CAS:Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormula:C7H13N3O4·H2OColor and Shape:White Off-White PowderMolecular weight:221.21Caprylic Acid
CAS:Saturated acyclic monocarboxylic acids and their anhydrides, halides, peroxides etc, nesoiFormula:C8H16O2Color and Shape:Colorless Clear Pale Yellow LiquidMolecular weight:144.11503Sesame Oil Related Compound A (1,2-dilinoleoyl-3-oleoyl-rac-glycerol) (OLL)
CAS:<p>Vegetable fats and oils and their fractions, hydrogenated, inter-esterified, reesterified or elaidinized, whether or not refined, not further prepared</p>Formula:C57H100O6Color and Shape:Translucent LiquidMolecular weight:881.4Powdered Chinese Salvia Extract
CAS:Vegetable saps and extracts, nesoiFormula:C36H30O16Color and Shape:Light Yellow Brown PowderMolecular weight:718.153382'-Fucosyllactose
CAS:Sugars, chemically pure, other than sucrose, lactose, maltose, glucose and fructose; sugar ethers and sugar esters, and their salts, nesoiFormula:C18H32O15Color and Shape:White Off-White PowderMolecular weight:488.17412Mepivacaine Hydrochloride
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C15H22N2O·HCIColor and Shape:White Crystalline PowderMolecular weight:282.8Dicyclomine Hydrochloride
CAS:Amino-alcohols, other than those containing more than oFormula:C19H35NO2·ClHColor and Shape:PowderMolecular weight:345.24346Norgestrel
CAS:Estrogens and progestinsFormula:C21H28O2Color and Shape:White Off-White Crystalline PowderMolecular weight:312.45 g/molSkim Milk Powder with Maltodextrin Level A
Milk and cream, concentrated, whether or not sweetened, in powder, granules or other solid forms, fat content not exceeding 1.5%Color and Shape:White Cream SolidFlecainide Acetate
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C17H20F6N2O3·C2H4O2Color and Shape:White Off-White Crystalline PowderMolecular weight:474.15894Lauryl Alcohol
CAS:Dodecan-1-ol (lauryl alcohol), hexadecan-1-ol (cetyl alcohol), and octadecan-1-ol (stearyl alcohol)Formula:C12H26OColor and Shape:White PowderMolecular weight:186.33 g/molTrandolapril Related Compound C ((2S, 3aR, 7aS)-1-[N-[(S)-1-Carboxy-3-cyclohexylpropyl]-L-alanyl]hexahydro-2-indolinecarboxylic acid 1-ethyl ester hydrochloride)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFormula:C24H40N2O5·HClColor and Shape:White Off-White PowderMolecular weight:436.29372Diethylene Glycol Monoethyl Ether
CAS:Monomethyl ethers of ethylene glycol or of diethylene glycolFormula:C6H14O3Color and Shape:Colorless Clear LiquidMolecular weight:134.09429Valsartan Related Compound E (N-valeryl-N-{[2'-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl}-L-valine methyl ester)
CAS:Aromatic or modified aromatic drugs with nitrogen heteroFormula:C25H31N5O3Color and Shape:PowderMolecular weight:449.24269Chlordiazepoxide Related Compound A (7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one 4-Oxide)
CAS:Antidepressants, tranquilizers and other psychotherapeutic agents, nesoiFormula:C15H11ClN2O2Color and Shape:White PowderMolecular weight:286.05091Polyisobutylene
CAS:Polyisobutylene,nesoiFormula:C(CH3)2CH2nColor and Shape:White Colorless Waxy SolidMolecular weight:~37000Zileuton Related Compound B (2-(Benzo[b]thien-2-oyl)benzo[b]thiophene)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C17H10OS2Color and Shape:Yellow Brown PowderMolecular weight:294.01731Iminodibenzyl (10,11-Dihydro-5H-dibenzo[b,f]azepine)
CAS:Aromatic or modified aromatic heterocyclic compounds with nitrogen hetero atom(s) only, except acridine, indole and carbazoleFormula:C14H13NColor and Shape:White Light Yellow PowderMolecular weight:195.27Orphenadrine Citrate
CAS:Aromatic drugs of amino-alcohols, other than those contg more than one kind of oxygen function, their ethers and esters; salts thereof, nesoiFormula:C18H23NO·C6H8O7Color and Shape:White Crystalline PowderMolecular weight:269.17796Ammonio Methacrylate Copolymer Type B
CAS:Other acrylic polymers in primary forms (excluding elastomeric)Formula:(C9H18NO2·C5H8O2·C5H8O2·Cl)xColor and Shape:White Colorless GranularMolecular weight:407.93N-Demethylazithromycin
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C37H70N2O12Color and Shape:White PowderMolecular weight:734.49288Gemifloxacin Related Compound B (7-[3-(Aminomethyl)-4-hydroxypyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid monomethanesulfonate)
CAS:Heterocyclic compounds (excluding aromatic or modified aromatic) withnitrogen hetero-atom(s) only nesoiFormula:C17H19FN4O4·CH4O3SColor and Shape:Off-White SolidMolecular weight:458.12715Triethylamine
CAS:Acyclic monoamines and their derivatives, nesoiFormula:C6H15NColor and Shape:Clear Colorless LiquidMolecular weight:101.12045Glycitein
CAS:Aromatic pesticides with oxygen hetero-atom(s) only neFormula:C16H12O5Color and Shape:Off-White Beige Crystalline PowderMolecular weight:284.06847Heparin Sodium Identification
CAS:Heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or includedFormula:C9H20N3NaO3Color and Shape:PowderMolecular weight:241.2632Choline Chloride
CAS:Choline and its saltsFormula:C5H14ClNOColor and Shape:White Crystalline PowderMolecular weight:139.07639Piroctone Related Compound A ((2-[5-methyl-3-(2,4,4-trimethylpentyl)-4,5-dihydroisoxazol-5-yl]acetic acid) 2-aminoethanol salt)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C16H32N2O4Color and Shape:Brown LiquidMolecular weight:316.44Dalfampridine Related Compound B (3,5-Dibromopyridin-4-amine)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C5H4Br2N2Color and Shape:Off-White SolidMolecular weight:251.91Cyclopentolate Hydrochloride
CAS:Aromatic drugs of amino-alcohols, other than those contg more than one kind of oxygen function, their ethers and esters; salts thereof, nesoiFormula:C17H25NO3·HCIColor and Shape:White Crystalline PowderMolecular weight:431.09574Isopropyl Myristate
CAS:Saturated acyclic monocarboxylic acids and their anhydrides, halides, peroxides etc, nesoiFormula:C17H34O2Color and Shape:Colorless Clear LiquidMolecular weight:270.46 g/molAminotriazinone (3-Amino-1,2,4-triazin-5(2H)-one)
CAS:Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFormula:C3H4N4OColor and Shape:SolidMolecular weight:112.03851Anhydrotetracycline Hydrochloride ((4S ,4aS ,12aS )-4-(Dimethylamino)-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-1,4,4a,5,12,12a-hexahydrotetracene-2-carboxamide monohydrochloride)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormula:C22H22N2O7·HClColor and Shape:Yellow SolidMolecular weight:462.11938Cefotaxime Sodium
CAS:Antibiotics nesoiFormula:C16H16N5NaO7S2Color and Shape:Off-White Light Yellow Crystalline PowderMolecular weight:477.03888Amphotericin B
CAS:Antibiotics nesoiFormula:C47H73NO17Color and Shape:Yellow Orange PowderMolecular weight:924.08Poloxamer Liquid
CAS:Cationic organic surface-active agents,other than aromatic or modified aromatic, whether or not for retail sale, non-ionic, nesoiFormula:HO(C2H4O)12(C3H6O)20(C2H4O)12HColor and Shape:Clear Cloudy LiquidMolecular weight:2235.47701Methyl Caprylate
CAS:Saturated acyclic monocarboxylic acids and their anhydrides, halides, peroxides etc, nesoiFormula:C9H18O2Color and Shape:Colorless LiquidMolecular weight:158.27[D-allo-Thr]13-Liraglutide
Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormula:C172H265N43O51Color and Shape:White PowderMolecular weight:3751.56Nicotinamide Riboside Chloride
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C11H15ClN2O5Color and Shape:White Off-White PowderMolecular weight:290.06695Decitabine Related Compound F (1-(2-Deoxy-D-ribofuranosyl)-3-guanylurea)
CAS:Compounds containing an unfused furan ring, whether or not hydrogenated, in the structure, nesoiFormula:C7H14N4O4Color and Shape:White Crystalline PowderMolecular weight:218.1015Temozolomide Related Compound C (diphenylcarbamic chloride)
CAS:Aromatic cyclic amides (including cyclic carbamates) anFormula:C13H10ClNOColor and Shape:PowderMolecular weight:231.04509N-Nitroso Dorzolamide Solution (1 mL ) ((4S,6S)-4-(ethyl(nitroso)amino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide)
Sulfonamides, nesoiFormula:C10H15N3O5S3Color and Shape:Colorless LiquidMolecular weight:353.01738Methylparaben
CAS:Carboxylic acids with phenol function but without otherFormula:C8H8O3Color and Shape:White Crystalline PowderMolecular weight:152.15[α-Glu(side chain)]-Semaglutide
Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormula:C187H291N45O59Color and Shape:White PowderMolecular weight:4111.11538Diluted Isosorbide Mononitrate Related Compound A (1,4:3,6-Dianhydro-D-glucitol 2-nitrate in lactose)
CAS:Heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C6H9NO6Color and Shape:White PowderMolecular weight:191.04299Fluticasone 2-(Fluoromethoxy)acetyl 5-chloro Furan-2-carboxylic Acid ((6α,11β,16α,17α)-6,9-Difluoro-17-{[(fluoromethyl)sulfanyl]carbonyl}-11-hydroxy-16-methyl-3-oxoandrosta-1,4-dien-17-yl 5-chloro-2-furoate)
Compounds containing an unfused furan ring, whether or not hydrogenated, in the structure, nesoiFormula:C27H28ClF3O6SColor and Shape:White PowderMolecular weight:572.12472T4-Ethyl Thyroxine (4-(4-Ethyl-2,6-diiodophenoxy)-2,6-diiodo-phenol)
CAS:Ether-phenols, ether-alcohol-phenols and their halogenated, sulfonated, nitrated or nitrosated derivativesFormula:C14H10I4O2Color and Shape:White PowderMolecular weight:717.68597Beclomethasone 9(11)-ene Dipropionate (16β-Methyl-3,20-dioxopregna-1,4,9(11)-triene-17,21-diyl dipropionate)
CAS:Carboxylic acids with aldehyde or ketone function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids andtheir derivFormula:C28H36O6Color and Shape:White PowderMolecular weight:468.582-Ethylhexyl Acrylate (2-Ethylhexyl 2-propenoate)
CAS:2-ethyl-1-hexyl acrylateFormula:C11H20O2Color and Shape:Colorless LiquidMolecular weight:184.146332-Methylhexacosane (2-methylhexacosane)
CAS:Saturated acyclic hydrocarbons, excluding ethane and butaneFormula:C27H56Color and Shape:White SolidMolecular weight:380.4382Vismodegib Related Compound A (N-(4-Chloro-3-(pyridin-2-yl)phenyl)-4-(methylsulfonyl)-2-nitrobenzamide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C19H14ClN3O5SColor and Shape:Off-White SolidMolecular weight:431.03427Carboxaamido Enzalutamide (4-(3-(4-carbamoyl-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluoro-N-methylbenzamide)
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormula:C21H18F4N4O3SColor and Shape:White SolidMolecular weight:482.10357Desfluoro Dolutegravir ((4R,12aS)-N-benzyl-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-arboxamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C20H21N3O5Color and Shape:Off-White PowderMolecular weight:383.42,4-Dimethylundecane (2,4-dimethylundecane)
CAS:Saturated acyclic hydrocarbons, excluding ethane and butaneFormula:C13H28Color and Shape:Colorless LiquidMolecular weight:184.2191Pseudoisoeugenyl 2-Methylbutyrate ((E)-4-Methoxy-2-(prop-1-en-1-yl)phenyl 2-methylbutanoate)
CAS:Carboxylic acids with aldehyde or ketone function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids andtheir derivFormula:C15H20O3Color and Shape:Pale Yellow LiquidMolecular weight:248.14124Miconazole
CAS:Compounds containing an unfused imidazole ring (whetherFormula:C18H14Cl4N2OColor and Shape:PowderMolecular weight:413.98602Polysorbate 40
CAS:Nonionic surface-active agents,aromatic or modified aromatic,whether or not put up for retail saleColor and Shape:Yellow LiquidMolecular weight:203.090615'-Adenylic Acid
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C10H14N5O7PColor and Shape:White Crystalline PowderMolecular weight:347.06308Carglumic Acid
CAS:Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormula:C6H10N2O5Color and Shape:White PowderMolecular weight:190.15Isorhamnetin
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C16H12O7Color and Shape:Light Yellow PowderMolecular weight:316.0583Cilostazol Related Compound B (6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-1H-quinolin-2-one)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormula:C20H25N5O2Color and Shape:White Brown PowderMolecular weight:367.20083Ramipril Related Compound B ((2S,3aS,6aS)-1-{[(S)-1-Methoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C24H34N2O5Color and Shape:White PowderMolecular weight:430.55Ethacrynic Acid
CAS:Carboxylic acids with additional oxygen function and thFormula:C13H12Cl2O4Color and Shape:White Off-White PowderMolecular weight:303.14Mefloquine Related Compound A (threo-mefloquine)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C17H16F6N2O·HClColor and Shape:White PowderMolecular weight:378.11668Flumazenil Related Compound B (Ethyl 8-hydroxy-5,6-dihydro-5-methyl-6-oxo-4H-imidazol-[1,5-a][1,4]benzodiazepine-3-carboxylate)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C15H15N3O4Color and Shape:White PowderMolecular weight:301.10626Memantine Related Compound I (3-Ethyladamantan-1-amine hydrochloride)
CAS:Cyclanic, cyclenic or cycloterpenic mono- or polyamines, and their derivatives; salts thereofFormula:C12H21N·HClColor and Shape:White PowderMolecular weight:215.14408Metformin Related Compound A (1-Cyanoguanidine)
CAS:1-cyanoguanidine (dicyandiamide)Formula:C2H4N4Color and Shape:White PowderMolecular weight:84.1Quinapril Related Compound B (3-Isoquinolinecarboxylic acid, 2-[2-[(1-carboxy-3-phenylpropyl)amino]-1-oxopropyl]-1,2,3,4-tetrahydro-,[3S-[2[R*(R*)],3R*]])
CAS:Drugs containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fusedFormula:C23H26N2O5Color and Shape:White PowderMolecular weight:410.47Albendazole Related Compound D (5-Propylsulfonylbenzimidazol-2-amine)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C10H13N3O2SColor and Shape:Light Brown SolidMolecular weight:239.07285Theophylline Related Compound F (7-(2-Hydroxyethyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione)
CAS:Theophylline and aminophylline (excluding fenetylline) and their derivatives, salts thereof, not elsewhere specified or includedFormula:C9H12N4O3Color and Shape:White PowderMolecular weight:224.09094Indomethacin Related Compound A (2-(5-methoxy-2-methyl-1H-indol-3-yl)acetic acid)
CAS:Aromatic or modified aromatic drugs with nitrogen heteroFormula:C12H13NO3Color and Shape:Light Yellow Crystalline PowderMolecular weight:219.08954Entacapone
CAS:Nitrile function compounds, nesoiFormula:C14H15N3O5Color and Shape:Yellow Green Crystalline PowderMolecular weight:305.10117Cetirizine Hydrochloride
CAS:Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFormula:C21H25ClN2O3·2HClColor and Shape:White PowderMolecular weight:388.15537Methyl Oleate
CAS:Salts and esters of oleic, linoleic, or linolenic acidsFormula:C19H36O2Color and Shape:Clear LiquidMolecular weight:296.27153Doxercalciferol
CAS:Other vitamins and their derivatives, nesoiFormula:C28H44O2Color and Shape:White Off-White PowderMolecular weight:412.65Milrinone
CAS:Lactams not elsewhere specified or includedFormula:C12H9N3OColor and Shape:PowderMolecular weight:211.07456Cefepime Related Compound D ((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetic acid)
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormula:C6H7N3O3SColor and Shape:Off-White Light Brown PowderMolecular weight:201.02081Naratriptan Hydrochloride
CAS:Sulfonamides used as drugsFormula:C17H25N3O2S·HClColor and Shape:White Pale Yellow PowderMolecular weight:335.16675Sulfacetamide Sodium
CAS:Sulfonamides used as drugsFormula:C8H10N2O3S·H2O·NaColor and Shape:White Light Yellow PowderMolecular weight:214.04121Spectinomycin Hydrochloride
CAS:Antibiotics nesoiFormula:C14H24N2O7·2HCl·5H2OColor and Shape:PowderMolecular weight:495.3Doxepin Related Compound C ((E,Z)-3-(Dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine hydrochloride)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C18H19NO·HClColor and Shape:Cream PowderMolecular weight:265.14666Dibutyl Sebacate
CAS:Azelaic acid, sebacic acid, their salts and estersFormula:C18H34O4Color and Shape:Colorless Clear LiquidMolecular weight:314.47 g/molOrlistat Related Compound A ((3S,4S)-3-Hexyl-4-[(2R)-2-hydroxytridecyl]-2-oxetanone)
CAS:Lactones nesoiFormula:C22H42O3Color and Shape:White PowderMolecular weight:354.58Plastic Additive 1 (Ethylene bis[3,3-bis[3-(1,1-dimethylethyl)-4-hydroxyphenyl] butanoate])
CAS:Carboxylic acids with phenol function but without other oxygen function, their anhydrides, halides, peroxides etc, nesoiFormula:C50H66O8Color and Shape:White SolidMolecular weight:794.47577Lurasidone Hydrochloride
CAS:Compounds containing a benzothiazole ring-system (whether or not hydrogenated), not further fusedFormula:C28H36N4O2S·HClColor and Shape:White Off-White PowderMolecular weight:528.23258Sulfamethizole
CAS:Sulfonamides used as drugsFormula:C9H10N4O2S2Color and Shape:White Light Yellow Crystalline PowderMolecular weight:270.02452Tioconazole Related Compound C (1-[2,4-Dichloro-β-[(5-bromo-2-chloro-3-thenyl)-oxy]-phenethyl]imidazole hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C16H12BrCl3N2OS·HClColor and Shape:Off-White PowderMolecular weight:463.89193Desfluoro Paliperidone (3-{2-[4-(Benzisoxazol-3-yl)piperidin-1-yl]ethyl}-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C23H28N4O3Color and Shape:Beige PowderMolecular weight:408.21614Tiotropium Related Compound A (Sodium 2-hydroxy-2,2-di(thiophen-2-yl)acetate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C10H7NaO3S2Color and Shape:White Coarse PowderMolecular weight:261.97343Ketorolac Methyl Ester (Methyl 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C16H15NO3Color and Shape:Off-White PowderMolecular weight:269.10519Montelukast Racemate
CAS:Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticidesFormula:C35H36ClNO3S·C12H23NColor and Shape:PowderMolecular weight:766.39349Pitavastatin Related Compound C (Calcium (S,4E,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3-hydroxyhepta-4,6-dienoate)
CAS:Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticidesFormula:Ca(C25H21FNO3)2Color and Shape:White Fine PowderMolecular weight:844.26368Clenbuterol Hydrochloride
CAS:Aromatic drugs of amino-alcohols, other than those contg > one kind of oxygen function, their ethers and esters; salts thereof, nesoiFormula:C12H18Cl2N2O·ClHColor and Shape:White Yellow Crystalline PowderMolecular weight:312.0563Cidofovir Related Compound B (1-[(S)-3-Hydroxy-2-(O,O-diethylphosphonomethoxy)propyl]cytosine hydrochloride)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C12H22N3O6P·HClColor and Shape:White Green Light Green PowderMolecular weight:371.1013Docusate Sodium
CAS:Acyclic polycarboxylic acids and their anhydrides, halides, peroxides and their derivatives, nesoiFormula:C20H37NaO7SColor and Shape:White Waxy SolidMolecular weight:444.21577Phenoxybenzamine Hydrochloride
CAS:Aromatic drugs of amino-alcohols, other than those contg > one kind of oxygen function, their ethers and esters; salts thereof, nesoiFormula:C18H22ClNO·HCIColor and Shape:White Off-White PowderMolecular weight:443.05129Clopidogrel Related Compound C (methyl (-)-(R)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate, hydrogen sulfate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C16H16ClNO2S·H2SO4Color and Shape:White PowderMolecular weight:419.9Coix Seed Oil Extract
CAS:Vegetable saps and extracts, nesoiFormula:C57H98O6Color and Shape:Light Yellow LiquidMolecular weight:878.73634Eleutheroside E (β-D-Glucopyranoside, (tetrahydro-1H,3H-furo(3,4-c)furan-1,4-diyl)bis(2,6-dimethoxy-4,1-phenylene)bis-)
CAS:Other glycosides, natural or reproduced by synthesis, and their salts, ethers, esters and other derivativesFormula:C34H46O18Color and Shape:White PowderMolecular weight:742.26841Calcitriol
CAS:Other vitamins and their derivatives, nesoiFormula:C27H44O3Color and Shape:Colorless White PowderMolecular weight:416.32905Olanzapine
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C17H20N4SColor and Shape:Off-White Yellow Crystalline PowderMolecular weight:312.14087Doxazosin Related Compound F (N,N'-bis(1,4-benzodioxane-2-carbonyl)piperazine)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C22H22N2O6Color and Shape:White Off-White PowderMolecular weight:410.14779Calcium Acetate
CAS:Other salts of acetic acid (excluding sodium acetate & cobalt acetates)Formula:C4H6CaO4Color and Shape:White PowderMolecular weight:158.17 g/molSolifenacin Identification Mixture B
Compounds (excluding drugs and pesticides) containing a quinoline or isoquinoline ringColor and Shape:PowderRiluzole Related Compound A (4-(Trifluoromethoxy)aniline)
CAS:Amino-naphthols and other amino-phenols, their ethers and esters, other than those cont more than one kind of oxygen function; salts thereof nesoiFormula:C7H6F3NOColor and Shape:Colorless Light Yellow LiquidMolecular weight:177.04015Levonordefrin
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormula:C9H13NO3Color and Shape:Grey Beige PowderMolecular weight:183.08954Paroxetine Related Compound C ((3R,4S)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride) OR ((+)-trans-Paroxetine hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H20FNO3·HClColor and Shape:White PowderMolecular weight:365.1194Metacresol
CAS:Cresols and their saltsFormula:C7H8OColor and Shape:Colorless Yellow LiquidMolecular weight:108.05751Methotrexate System Suitability Mixture (Mixture of Methotrexate, Methotrexate Related Compound H, Methotrexate Related Compound I, and Methotrexate Dimethylester Hydrochloride)
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiColor and Shape:Pale Yellow PowderCephradine
CAS:Antibiotics nesoiFormula:C16H19N3O4S·H2OColor and Shape:White Off-White Crystalline PowderMolecular weight:367.42Cefadroxil Related Compound D ((6R,7R)-7-[(S)-2-Amino-2-(4-hydroxyphenyl)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid)
CAS:Aminoglycoside antibioticsFormula:C16H17N3O5SColor and Shape:White PowderMolecular weight:363.08889L-Glutamic Acid Hydrochloride
CAS:Glutamic acid and its saltsFormula:C5H9NO4·HCIColor and Shape:PowderMolecular weight:286.96545Melengestrol Acetate Related Compound A (16-Methylene-3,20-dioxopregn-4-en-17-yl acetate)
CAS:Estrogens and progestinsFormula:C24H32O4Color and Shape:Pale Yellow Off-White PowderMolecular weight:384.51Calcium Succinate
CAS:Acyclic polycarboxylic acids and their anhydrides, halides, peroxides and their derivatives, nesoiFormula:C4H4CaO4·H2OColor and Shape:PowderMolecular weight:173.98411Mifepristone
CAS:Adrenal cortical hormones and their derivatives nesoiFormula:C29H35NO2Color and Shape:Yellow PowderMolecular weight:429.26678Methimazole
CAS:Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFormula:C4H6N2SColor and Shape:White PowderMolecular weight:114.17Celecoxib Related Compound A (4-[5-(3-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide)
CAS:Sulfonamides, nesoiFormula:C17H14F3N3O2SColor and Shape:White PowderMolecular weight:381.07588Naftifine Hydrochloride
CAS:Aromatic monoamines not elsewhere specified or included and their derivatives, salts therofFormula:C21H21N·HClColor and Shape:White PowderMolecular weight:287.1674Albendazole Related Compound A (5-Propylthiobenzimidazol-2-amine)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C10H13N3SColor and Shape:White Off-White SolidMolecular weight:207.3 g/molTeriflunomide Related Compound B (2-Cyano-N-(4-(trifluoromethyl)phenyl)acetamide)
CAS:Nitrile function compounds, nesoiFormula:C10H7F3N2OColor and Shape:White Yellow Crystalline PowderMolecular weight:228.05105Racepinephrine Hydrochloride
CAS:Catecholamine hormones (excluding epinephrine), their derivatives and structural analoguesFormula:C9H13NO3·HClColor and Shape:White Light Yellow Crystalline PowderMolecular weight:219.67Meperidine Related Compound A (Ethyl 1-ethyl-4-phenylpiperidine-4-carboxylate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C16H23NO2Color and Shape:Light Yellow LiquidMolecular weight:261.17288Quinidine Sulfate
CAS:Alkaloids of cinchona (excluding quinine and its salts) and their derivatives; salts thereofFormula:(C20H24N2O2)2·H2SO4·2H2OColor and Shape:White PowderMolecular weight:648.36756Propylthiouracil
CAS:Drugs containing a pyrimidine ring (whether or not hydrFormula:C7H10N2OSColor and Shape:White Crystalline PowderMolecular weight:170.23 g/molSteviol Glycosides System Suitability
CAS:Other glycosides, natural or reproduced by synthesis, and their salts, ethers, esters and other derivativesColor and Shape:White Off-White PowderClomipramine Related Compound C (3-(3-Chloro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine hydrochloride, monohydrate)
CAS:Aromatic or modified aromatic drugs with nitrogen hetero-atom(s) only, not elsewhere specified or includedFormula:C19H21ClN2·HClColor and Shape:Yellow PowderMolecular weight:367.32Piperazine
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C4H10N2Color and Shape:White Off-White FlakesMolecular weight:86.0844N1-(2-Chloroethyl)-N2-(2,3-dichlorophenyl)ethane-1,2-diamine hydrochloride (N1-(2-chloroethyl)-N2-(2,3-dichlorophenyl)ethane-1,2-diamine, hydrochloride)
CAS:Aromatic polyamines and their derivatives, salts thereof, nesoiFormula:C10H13Cl3N2·HClColor and Shape:White Off-White SolidMolecular weight:266.01443Doxazosin Related Compound D (1,4-benzodioxane-2-carboxylic acid)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C9H8O4Color and Shape:Off-White Crystalline PowderMolecular weight:180.04226Ticagrelor Related Compound A ((1R,2S)-2-(3,4-difluorophenyl)cyclopropan-1-amine (R)-mandelate)
CAS:Aromatic monoamines not elsewhere specified or included and their derivatives, salts therofFormula:C9H9F2N·C8H8O3Color and Shape:White Yellow SolidMolecular weight:321.11765Ranolazine Related Compound D (2,2'-(Piperazine-1,4-diyl)bis[N-(2,6-dimethylphenyl)acetamide])
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C24H32N4O2Color and Shape:White Off-White PowderMolecular weight:408.25253Hydroxyethyl Cellulose
CAS:Cellulose ethers,nesoiColor and Shape:White Light Grey PowderMolecular weight:203.09061Zolmitriptan Related Compound E ((S)-N,N-dimethyl-2-{5-[(2-oxooxazolidin-4-yl)methyl]-1H-indol-3-yl}ethanamine oxide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C16H21N3O3Color and Shape:Off-White PowderMolecular weight:303.15829o-Celecoxib (4-(5-(o-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide)
CAS:Sulfonamides, nesoiFormula:C17H14F3N3O2SColor and Shape:White Off-White SolidMolecular weight:381.07588Dipyridamole Related Compound F (2,2',2'',2'''-({4-[(2-Hydroxyethyl)amino]-8-(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,6-diyl}bis(azanetriyl))tetraethanol)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormula:C21H36N8O5Color and Shape:SolidMolecular weight:480.28087Ioxaglic Acid
CAS:Aromatic cyclic amides (including cyclic carbamates) anFormula:C24H21I6N5O8Color and Shape:White Off-White PowderMolecular weight:1268.56584Telmisartan Related Compound B (4'-[(1,7'-dimethyl-2'-propyl-1H,1'H-2,5'-bibenzo[d]imidazol-1'-yl)methyl]biphenyl-2-carboxylic acid)
CAS:Drugs with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C33H30N4O2Color and Shape:White PowderMolecular weight:514.62Potassium Sorbate
CAS:Potassium sorbateFormula:C6H7KO2Color and Shape:White GranularMolecular weight:150.00831Cimetidine
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormula:C10H16N6SColor and Shape:White Off-White Crystalline PowderMolecular weight:252.11572Lansoprazole Related Compound B (2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-pyridin-2-yl]methyl]sulfanyl]-1H-benzimidazole monohydrate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C16H14F3N3OS·H2OColor and Shape:Brown Crystalline PowderMolecular weight:353.08097Heptane
CAS:Saturated acyclic hydrocarbons (excl ethane and butane)Formula:C7H16Color and Shape:Colorless Clear LiquidMolecular weight:100.2 g/molValacyclovir Related Compound G (N,N-dimethylpyridin-4-amine)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C7H10N2Color and Shape:White CrystalsMolecular weight:122.17 g/molAripiprazole Acid Analog (4-((2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)oxy)butanoic acid)
CAS:Lactams, nesoiFormula:C13H15NO4Color and Shape:White Off-White SolidMolecular weight:249.10011Minoxidil Related Compound E (6-(Piperidin-1-yl)pyrimidine-2,4-diamine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C9H15N5Color and Shape:Off-White Beige PowderMolecular weight:193.13275
![Cefadroxil Related Compound D ((6R,7R)-7-[(S)-2-Amino-2-(4-hydroxyphenyl)acetamido]-3-methyl-8-oxo…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1097148.webp&w=3840&q=75)
![Zolmitriptan Related Compound E ((S)-N,N-dimethyl-2-{5-[(2-oxooxazolidin-4-yl)methyl]-1H-indol-3-y…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1727064.webp&w=3840&q=75)
